Home > Healthcare > Medical Devices > Implantable Devices > Annuloplasty System Market

Annuloplasty System Market Trends

  • Report ID: GMI9243
  • Published Date: Apr 2024
  • Report Format: PDF

Annuloplasty System Market Trends

  • Technological advancements in annuloplasty systems play a pivotal role in shaping the landscape of valvular heart disease treatment. These innovative systems, comprising annuloplasty rings and bands, are revolutionizing the way clinicians repair and reconstruct heart valves, offering enhanced durability, precision, and patient outcomes.
     
  • Ongoing technological innovations have led to the development of annuloplasty systems with improved durability and longevity. Advanced materials, such as biocompatible polymers and alloy combinations, are being utilized to construct annuloplasty rings and bands that exhibit greater resistance to wear, corrosion, and deformation over time.
     
  • For instance, Kalangos annuloplasty ring developed by Bioring SA is made from biodegradable polymer called polydioxanone, which allows it to degrade over time. These cardiovascular devices are designed to induce the growth of autologous fibrous tissue, reinforcing the deficient annulus.
     
  • Moreover, technological advancements have enabled the incorporation of innovative design features into annuloplasty systems, enhancing their efficacy and performance. For instance, the contour 3D annuloplasty ring is a remodeling ring with a unique 3D curvature based on computed tomography (CT) data from functional tricuspid valves.
     
  • Additionally, advanced imaging technologies, such as echocardiography and MRI systems, aid in the precise positioning and placement of annuloplasty devices during surgery, ensuring optimal valve function and long-term durability.
     
  • Thus, technological advancements in annuloplasty systems, characterized by enhanced durability, innovative design, compatibility with minimally invasive approaches, and biocompatibility, are factors driving growth of annuloplasty systems market.
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Annuloplasty system market size was USD 473.9 million in 2023 and will grow at an 8.2% CAGR between 2024 and 2032, propelled by rising prevalence of valvular heart diseases, advancements in minimally invasive surgical techniques, and aging populationsworldwide.

The mitral valve repair application segment recorded USD 240.8 million in 2023 due to their ability to preserve valve function and mitigate risks associated with prosthetic devices.

North America annuloplasty system industry recorded USD 198.5 million in 2023 and will expand at 7.8% CAGR till 2032, owing to advanced healthcare infrastructure, high prevalence rates of cardiovascular diseases, and extensive adoption of innovative medical technologies.

Abbott Laboratories, Affluent Medical, BioStable Science & Engineering, Corcym UK Limited, Coroneo, Edwards Lifesciences Corporation, Genesee BioMedical, Medtentia International Ltd Oy, Medtronic plc, and Micro Interventional Devices Incorporated among others.

Annuloplasty System Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 150
  • Countries covered: 23
  • Pages: 110
 Download Free Sample